Carlum Shiu
B.Sc. The University of Birmingham M.Sc. London School of Hygiene and Tropical Medicine Ph.D. The National Institute for Medical Research European Collection of Cell Cultures Postdoctoral Fellow at Johns Hopkins School of Medicine
| Headline: | Entrepreneur |
| Work status: | Living The Dream |
| Website: | http://www.aegispacific.net |
| Industries: | Biotech, Health, Nanotech |
| Skills: | Chinese, English, Languages |
| Location: | Tokyo |
| Visas: | UK, Japan |
| Interested in: | Advising startups, Brainstorming, Career advice, Consulting opportunities, Finding business partners, Finding cofounders, Finding experts, Finding team mates, Giving back, Growing my group, Helping friends, Investing in projects, Meeting new people, Mentoring, Offering Expertise, Partnering with other groups, Professional opportunities, Promoting my startups, Providing services to startups, Recruiting, Recruiting for my startup, Starting a company |
| Tags: | asia pacific, Japan |
| Schools: | University of Birmingham |
FULL BIO
I had a long scientific career, focused upon infectious diseases and virology in particular. I studied HIV at a molecular level since my M.Sc. and conducted 4 years of postdoctoral studies at The Johns Hopkins School of Medicine.
Throughout my scientific career, I have sought to move beyond the bench and try to realise results in the faster business environments. I am now looking to consult for companies interested in the global healthcare markets, with an emphasis on Asia-Pacific.
WORK EXPERIENCE
| Employer: | Coral Cay Conservation |
| Position: | Volunteer |
| Description: | • Volunteer work with Coral Cay Conservation in the Philippines, assisted the survey of coral reefs to empower local management efforts. |
| Employer: | Johns Hopkins School of Medicine, US |
| Position: | Postdoctoral Fellow |
| Time period: | December 2005 - November 2008 |
| Description: | • Analysed the effects of a HIV-1 therapeutic vaccine Phase 1 Clinical Trial in infected adolescents.
• Supervised undergraduate students, incorporated modern technological platforms into laboratory protocols. |
| Employer: | Johns Hopkins School of Medicine, US |
| Position: | Postdoctoral Fellow |
| Time period: | December 2003 - November 2006 |
| Description: | • Investigated the effects of HIV, alcohol and malaria upon the blood brain barrier.
• Studied various elements simultaneously in a challenging environment. • Acquired a vast array of technical laboratory skills. • Maintained and organized the laboratory. |
| Employer: | The Centre for Applied Microbiological Research, UK |
| Position: | Laboratory Technician |
| Time period: | December 1996 - November 1998 |
| Description: | • Experience with a GLP environment in the Quality Control division, working to ISO 9001:2000 standards.
• Independently developed an assay for the authentication of animal cell lines. |
| Employer: | University of Birmingham, UK |
| Position: | Scholarship |
| Time period: | December 1996 - November 1997 |
| Description: | • Nuffield Foundation Bursary Award for an extracurricular student project.
• Acquired experience in technically challenging laboratory skills during the study. |
EDUCATION
| University: | University of Birmingham |
| Time period: | 1999 |
| Degree: | Biological Sciences, Microbiology, BSc |
PUBLICATIONS
| Papers: | C Shiu, E Barbier, F Di Cello, H Choi and M Stins. (2007) HIV-1 gp120 as well as alcohol affect blood brain barrier permeability and stress fiber formation: involvement of reactive oxygen species. Alcohol Clin. Exp. Res. 31 (1): 130-7.
In preparation C Shiu, C Cunningham, C Ziemniak, P Muresan, L Fox, E Sheeran, A Gaur, I Febo, K Luzuriaga, D Persaud and Pediatric AIDS Clinical Trials Group P1059 Team (2008). Evidence for Convergent Evolution in Low-Level Viremia in HIV-1 RT Among HLA-A*2/A*2-Supertype Positive Infected Individuals, Receiving Modified Vaccinia Ankara/Fowlpox Vaccines While on HAART. |
INFORMATION
| Awards: | Young Investigator Award |
Carlum's Startups (1)
View all
Carlum is Following (36)
View all-
RefleXion Medical
RefleXion Medical is developing a non-invasive way for tumors to signal their location during treatment, vastly improving radiation therapy.
-
Magenta
Imagine a mouse with the strength of an elephant: Magenta will replace the 2m-long superconducting coil in an MRI by a matrix of very small, very powerful magnets. We will not only reduce cost by 60% but also enable revolutionary new MRI designs.
-
ChemoCentryx
ChemoCentryx is focused exclusively on the discovery, development and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.
-
Stemgent
We provide proprietary reagents and tools developed and proven for reproducibility by some of the world's leading stem cell scientists.